Debt - Schedule of the Oramed Note (Details) - Senior Notes [Member] $ in Thousands |
6 Months Ended |
|---|---|
|
Jun. 30, 2026
USD ($)
| |
| Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] | |
| Ending Balance as of December 31, 2025 | $ 27,688 |
| Change in fair value of Oramed Note - recorded in the unaudited condensed consolidated statements of operations and comprehensive loss | 1,080 |
| Ending Balance as of June 30, 2026 | $ 28,768 |
| X | ||||||||||
- Definition Change In Fair Value In Operations And Comprehensive Loss No definition available.
|
| X | ||||||||||
- Definition Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|